<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the role of autophagy on the pathogenesis of spinocerebellar <z:hpo ids='HP_0001251'>ataxia</z:hpo> 3/<z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: HEK293 cells expressing polyglutamine-expanded ataxin-3 were used as cell model for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The level of polyglutamine-expanded ataxin-3 was detected after cells were treated with different inhibitors or inducer of autophagy </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Inhibition of autophagy increased aggregate formation and cell <z:hpo ids='HP_0011420'>death</z:hpo> in HEK293 cells expressing mutated ataxin-3, and vice versa </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSION: The data suggested that autophagy is involved in the degradation of mutant ataxin-3, resulting in a decrease in the proportions of aggregate-containing cells and cell <z:hpo ids='HP_0011420'>death</z:hpo> in HEK293 cells expressing polyglutamine-expanded ataxin-3 </plain></SENT>
<SENT sid="5" pm="."><plain>It is possible that autophagy may be applied as a potential therapeutic approach for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> </plain></SENT>
</text></document>